Eli Lilly on Friday crossed the $1 trillion market-cap threshold, becoming the first drugmaker to ever reach that milestone.

Bravo TV host Andy Cohen told the TODAY show that microdosing a GLP-1 drug helped him lose “a good chunk of weight.” The ...

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

In fact, emerging science suggests GLP-1s may support heart health, improve sleep quality and even help with addiction ...

“In general, we tend to see more weight loss with GLP-1-based medication treatment in patients who are female, those who do ...

Influential hairstylist and hair health expert Tom Smith adds that rapid weight loss can also put your body into a state of ...

CivicScience engages directly with consumers, collecting over one million survey responses daily, to turn real-time insights ...

Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...

The deal would lower the price of GLP-1s Ozempic, Wegovy, and Zepbound to about $350 a month, a savings of about $700, for ...

By 2030, households with GLP-1 users are projected to represent 35% of all food and beverage units sold, the consumer ...